Efficacy definitions for migraine studies

被引：16

作者：

Goldstein, DJ

Offen, WW

Moster, MB

机构：

[1] Lilly Res Labs, Neurosci Therapeut Area, Indianapolis, IN USA

[2] Indiana Univ, Med Ctr, Dept Pharmacol & Toxicol, Indianapolis, IN USA

[3] Methodist Hosp Indiana, Dept Pediat, Indianapolis, IN 46202 USA

来源：

CEPHALALGIA | 1999年 / 19卷 / 04期

关键词：

D O I：

10.1046/j.1468-2982.1999.019004248.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：248 / 249

页数：2

共 7 条

[1]

CUTLER N, 1995, NEUROLOGY, V45, pS5

[2] Double-blind, placebo-controlled, dose-finding study of rizatriptan (MK-462) in the acute treatment of migraine [J].

Gijsman, H ;

Kramer, MS ;

Sargent, J ;

Tuchman, M ;

MatzuraWolfe, D ;

Polis, A ;

Teall, J ;

Block, G ;

Ferrari, MD .

CEPHALALGIA, 1997, 17 (06) :647-651

[3] Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study [J].

Klassen, A ;

Elkind, A ;

Asgharnejad, M ;

Laurenza, A .

HEADACHE, 1997, 37 (10) :640-645

[4] Naratriptan is effective and well tolerated in the acute treatment of migraine - Results of a double-blind, placebo-controlled, crossover study [J].

Mathew, NT ;

Asgharnejad, M ;

Peykamian, M ;

Laurenza, A .

NEUROLOGY, 1997, 49 (06) :1485-1490

[5] Optimizing the dose of zolmitriptan (Zomig,* 311C90) for the acute treatment of migraine - A multicenter, double-blind, placebo-controlled, dose range-finding study [J].

Rapoport, AM ;

Ramadan, NM ;

Adelman, JU ;

Mathew, NT ;

Elkind, AH ;

Kudrow, DB ;

Earl, NL .

NEUROLOGY, 1997, 49 (05) :1210-1218

[6]

SARGENT J, 1995, NEUROLOGY, V45, pS10

[7] GUIDELINES FOR CONTROLLED TRIALS OF DRUGS IN MIGRAINE .1. EDITION [J].

TFELTHANSEN, P .

CEPHALALGIA, 1991, 11 (01) :1-12

← 1 →